Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Oncology

‘Off the charts’: the key breakthroughs giving new hope in treating cancer

World’s largest cancer conference in Chicago shares ‘impressive’ findings in vaccines, drug trials and AI

The Guardian - UK

Cancer patients say they were turned away from New Mexico hospital

‘They didn’t even try to make it work,’ one oncology patient said of Memorial Medical Center

The Independent UK

3 Pharma Stocks Delivering Exciting April Returns

The pharmaceutical industry is expected to grow rapidly due to the ever-rising healthcare needs, increasing demand for innovative medications, and technological advancements. Therefore, fundamentally strong pharmaceutical stocks Dr. Reddy’s (RDY), Teva Pharmaceutical Industries (TEVA), and AbbVie (ABBV) could be worth adding to your portfolio. Read on.

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Advancing cancer care with emerging technology: A fine balance

The breakthroughs in cutting-edge medical technologies for cancer care are remarkable. It seems like every day we are reading about ground-breaking progress that can change the fundamental premise of medical care delivery. Wearable technology, molecular testing and point-of-care devices promise hospital-level care at home, but established technologies like robotic surgery…

The Times of India

Up 825% So Far in 2024, Can This Penny Stock Go Any Higher?

Despite its outsized year-to-date gains, Wall Street expects this breakout penny stock to soar 55% higher, on average.

Barchart

Next-Gen Cancer Therapies Could Spark Upside for AstraZeneca Stock

Next-generation cancer therapies are here. AstraZeneca - already an oncology leader - is going down the path of radiopharmaceuticals with its purchase of Fusion. Along with the other potential blockbuster drugs in its pipeline, this should bode well for growth at AZN.

Barchart

3 Pharma Stocks Fueling Investor Enthusiasm

The pharmaceutical industry is expected to expand rapidly due to growing global healthcare needs and advancements in technology. Therefore, fundamentally strong pharma stocks Merck (MRK), AbbVie (ABBV), and GSK plc (GSK) might be ideal additions to your portfolio. Read on.

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Exclusive: 'Radiation therapy is curative in many cancers and has seen significant advancement'

The c-word strikes most people like a thunderbolt, impacting the psyche as a disease with no cure and very dismal chances of survival. Fortunately, recent advancements in medication and technology have significantly increased the survival rate of cancer patients worldwide. Even in cases where cancer is detected at a later…

The Times of India

Oncology Park will help bring down cancer medicine prices, says Rajeeve

Commissioning of Oncology Park in Kerala to reduce cancer medicine prices, boost sales, and achieve ₹1,000 crore turnover.

The Hindu

We've Just Scratched The Surface Of What Vaccines Can Achieve

The rapid development of Covid-19 vaccines was a historic medical triumph. But hastening the end of the pandemic may only be the beginning.

International Business Times

Telix posts first profit as sales triple to $502m

Melbourne-based radiation oncology business Telix Pharmaceuticals has made its first-ever profit after strong sales for its prostate cancer imaging agent.

AAP

'Wonder' drug to treat aggressive form of lung cancer promises hope

A new drug that can increase survival rates and average survival of cancer patients! Seems futuristic, right? Well, researchers at the Queen Mary University London have found a new drug that can work against a difficult-to-treat and aggressive form of cancer, mesothelioma. The findings of the study have been published…

The Times of India

Kidwai working on a State childhood cancer management policy

The State-run Kidwai Memorial Institute of Oncology (KMIO) is working on a comprehensive State childhood cancer management policy

The Hindu

Kidwai director shunted out based on committee’s report

Based on the report by a three-member committee headed by Arundathi Chandrashekar, Commissioner of Treasuries, to probe allegations of irregularities in the State-run Kidwai Memorial Institute of Oncology, the State government on Tuesday shunted out its director V. Lokesh. Syed Altaf, professor and head of the Department of Surgical Oncology…

The Hindu

Get all your
news in one place.

100's of premium titles.
One news app.

The Hindu

Sri Balaji Institute of Oncology in Tirupati set to carve a niche in cancer treatment

Sri Balaji Institute of Oncology (SBIO), being set up in Tirupati under the aegis of Sri Venkateswara Institute of Medical Sciences (SVIMS University), is all set to become a gamechanger in offering sophisticated cancer treatment at an affordable price to the commoners.

The Hindu

Preventive oncology clinics to come up in all districts

The Health department has plans to start preventive oncology clinics in all districts, according to a statement issued here by Health Minister Veena George on the eve of World Cancer Day on February 4.

The Hindu

From genomic medicine, a revolution rolls towards cancer care

Cancer genomics has the potential to transform cancer care by providing personalised treatments based on genomic data.

Barchart

Chart of the Day: Summit Therapeutics Begins to Soar

Caution: This company has had legal issues in the past. It is highly speculative. The Chart of the Day belongs to the oncology company Summit Therapeutics (SMMT) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha,...

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Kura Oncology (KURA) Offers Speculators a Profit-Scalping Opportunity

With bullish traders anticipating a quick pop in KURA stock, outside observers need to pay attention, especially because of the underlying short position.

Barchart

Chart of the Day: Autolus Therapeutics - Effective Cancer Treatments

The Chart of the Day belongs to the oncology based biomedical company Autolus Therapeutics (AUTL) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used...

The Independent UK

Top doctors warn of crisis in availability of breast cancer services

‘Massive’ shortage of specialist doctors and nurses triggers dangerous delays in treatment for thousands of women – with some services close to collapse

The Times of India

Immunotherapy in gastrointestinal oncology: A new dawn for cancer treatment

Gastrointestinal (GI) cancers, including cancers of the colon, stomach, esophagus, pancreas, and liver, affect millions of people worldwide and remain a leading cause of mortality. While surgery remains the gold standard treatment for curing GI cancers, chemotherapy and radiation therapy help in downstaging the disease and reduce the risk of…

WEKU

UK Markey Cancer Center genetic counselor says Lt. Gov. Coleman’s advice sets ‘beautiful example

Lieutenant Governor Jacqueline Coleman announced Monday that she underwent a double mastectomy in part because of a significant family history of cancer. Michael Gosky is a senior oncology genetic counselor at UK’s Markey Cancer Center. He said Coleman’s statement could lead to other Kentuckians having important family chats.

International Business Times UK

Groundbreaking AI-Powered Precision Medicine Startup, ImpriMed, Ventures into Human Oncology

With its AI-powered technology, the company has developed a groundbreaking solution for identifying optimal drug treatments for individual dogs and cats with blood cancers.

StockNews.com

3 A-Rated Biotech Stocks for Your 2024 Portfolio

Inelastic demand for healthcare products and services and the increasing government initiatives around the world are expected to boost the biotech industry. Therefore, it could be wise to buy fundamentally strong biotech stocks Entrada Therapeutics (TRDA), Corcept Therapeutics (CORT), and Alkermes (ALKS) this year. Read more.

1 … 6 7 8 9

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Medical Pharmaceuticals

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.